<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">39341219</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-4457</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Lancet. Infectious diseases</Title><ISOAbbreviation>Lancet Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination.</ArticleTitle><Pagination><StartPage>e674</StartPage><EndPage>e676</EndPage><MedlinePgn>e674-e676</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1473-3099(24)00603-0</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1473-3099(24)00603-0</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Happle</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany; Department of Pediatric Pulmonology, Allergology, and Neonatology, Hannover Medical School, Hannover 30625, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempf</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nehlmeier</LastName><ForeName>Inga</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stankov</LastName><ForeName>Metodi V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calderon Hampel</LastName><ForeName>Noemi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany; Cluster of Excellence RESIST EXC 2155, Hannover Medical School, Hannover 30625, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pöhlmann</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany; Faculty of Biology and Psychology, Georg August University of Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrens</LastName><ForeName>Georg M N</ForeName><Initials>GMN</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany; Center for Individualized Infection Medicine (CiiM), Hannover, Germany. Electronic address: Behrens.georg@mh-hannover.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dopfer-Jablonka</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Hannover 30625, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lancet Infect Dis</MedlineTA><NlmUniqueID>101130150</NlmUniqueID><ISSNLinking>1473-3099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>SP declares conducting contract research (testing of vaccinee sera for neutralising activity against SARS-CoV-2) for Valneva, unrelated to this work, and serving as an advisor for BioNTech, unrelated to this work. GMNB declares serving as a lecturer for Pfizer, unrelated to this work. AD-J declares serving as an advisor for Pfizer, unrelated to this work. TW declares serving as an advisor for Pfizer, unrelated to this work. All other authors declare no competing interests. GMNB and AD-J acknowledge funding from Niedersächsisches Ministerium für Wissenschaft und Kultur (the Ministry of Science and Culture of Lower Saxony; 14-76103-184) and the COVID-19-Research Network Lower Saxony (COFONI) (project 4LZF23). GMNB acknowledges funding by the European Regional Development Fund (ZW7-85151373). AD-J acknowledges funding by the European Social Fund (ZAM5-87006761). TW acknowledges funding by the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) under Germany's Excellence Strategy EXC 2155 RESIST (project 390874280). SP acknowledges funding by the EU project UNDINE (grant agreement number 101057100), COFONI through funding from the Ministry of Science and Culture of Lower Saxony (14-76103-184—projects 7FF22, 6FF22, and 10FF22) and DFG (PO 716/11-1). The funders had no role in the design and execution of the study, the writing of the manuscript, and the decision to submit the manuscript for publication. The authors did not receive payment by a pharmaceutical company or other agency to write the publication. All authors had access to the data and accept responsibility to submit for publication. CH and MH are joint first authors. GMNB and AD-J are joint senior authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39341219</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(24)00603-0</ArticleId><ArticleId IdType="pii">S1473-3099(24)00603-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle>